Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata is caused by the immune system attacking hair follicles.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Lack of vitamin D might cause hair loss due to autoimmune problems, and fixing vitamin D levels could help treat it.

Many children with alopecia areata also have other autoimmune diseases.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.